Page last updated: 2024-11-02

pentoxifylline and Neoplasms, Otorhinolaryngologic

pentoxifylline has been researched along with Neoplasms, Otorhinolaryngologic in 2 studies

Research Excerpts

ExcerptRelevanceReference
"Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment."5.43Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases. ( Bohn, JC; Sassi, LM; Schussel, JL; Stramandinoli-Zanicotti, RT, 2016)
"Osteoradionecrosis is a complication of head and neck radiotherapy, with a difficult resolution and no well-established treatment."1.43Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases. ( Bohn, JC; Sassi, LM; Schussel, JL; Stramandinoli-Zanicotti, RT, 2016)
"Oral mucositis is a frequent early side effect of radio(chemo)therapy of head-and-neck malignancies."1.42Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies. ( Bozsaky, E; Dörr, W; Gruber, S; Haagen, J; Habelt, B; Puttrich, M; Schmidt, M; Wolfram, K, 2015)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gruber, S1
Schmidt, M1
Bozsaky, E1
Wolfram, K1
Haagen, J1
Habelt, B1
Puttrich, M1
Dörr, W1
Bohn, JC1
Schussel, JL1
Stramandinoli-Zanicotti, RT1
Sassi, LM1

Other Studies

2 other studies available for pentoxifylline and Neoplasms, Otorhinolaryngologic

ArticleYear
Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies.
    Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2015, Volume: 191, Issue:3

    Topics: Animals; Disease Models, Animal; Dose Fractionation, Radiation; Female; Male; Mice; Mice, Inbred C3H

2015
Tissue repair in osteoradionecrosis using pentoxifylline and tocopherol--report of three cases.
    Oral and maxillofacial surgery, 2016, Volume: 20, Issue:1

    Topics: Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Thera

2016